RE: Maths. MO27 Feb 2020 19:02
Mathsproof, I don't see much reason to be anything other than negative at the moment.
In terms of the compounds I would say that this is the expected risk of investing in a biotech.
However I don't think a lack of trust in the BOD is a run of the mill risk.
I want the company to succeed, but funding is an issue.
How can we get over the trust hurdle?
We are in a stand off, the BOD could do something to build trust. The ideas that have been floated include BOD pay cuts and share purchase.
How about an alternative? How about giving the green light to the consolidation, but at a price?) if GM were to go perhaps?
I don't think that idea will fly either. The BOD have given no indication that they will take any action themselves to support the company, nor any indication that they will address the trust issue or even that there is a trust issue. There is no indication that the BOD want anything else other than business as usual. Its that which makes me think it is the BOD that is killing this company.